CN101579412B - Medicinal composition for treating prostatauxe and preparation method thereof - Google Patents
Medicinal composition for treating prostatauxe and preparation method thereof Download PDFInfo
- Publication number
- CN101579412B CN101579412B CN2008101067874A CN200810106787A CN101579412B CN 101579412 B CN101579412 B CN 101579412B CN 2008101067874 A CN2008101067874 A CN 2008101067874A CN 200810106787 A CN200810106787 A CN 200810106787A CN 101579412 B CN101579412 B CN 101579412B
- Authority
- CN
- China
- Prior art keywords
- pharmaceutical composition
- preparation
- weight portion
- pill
- capsule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicinal composition for treating prostatauxe, which consists of red infested rice, red paeony root and turtle shells. The medicinal composition is added with the conventional accessories and made into clinically acceptable medicament formulations according to the prior process. The medicinal composition has remarkable effect of treating the prostatauxe and no side effects.
Description
Technical field
The present invention relates to a kind of pharmaceutical composition, particularly relate to a kind of pharmaceutical composition for the treatment of prostate hyperplasia.
Background technology
In recent years prostate hyperplasia becomes modern's commonly encountered diseases, and prostate is the vitals of male reproductive system, and the prostatic fluid that its produces also is the important component part of seminal fluid, and it also has the nutrition sperm, impels the effect of ovum fertilization.And prostate is the place of most men " eventful ", and prostate hyperplasia is to develop formation gradually.Through clinical verification, the prostate hyperplasia that the male all had later in various degree in 55 years old.Therefore be the very important commonly encountered diseases of male.The reason that causes prostate hyperplasia is had different versions, and classical symptom is testis portion discomfort, lumbago, frequent micturition, the scorching hot twinge of urethral orifice and secretions is arranged.
Summary of the invention
The object of the invention is to provide a kind of pharmaceutical composition for the treatment of prostate hyperplasia and preparation method thereof.
Another purpose of the present invention is to provide the new purposes of this pharmaceutical composition.
The present invention is achieved through the following technical solutions:
The crude drug of pharmaceutical composition of the present invention consists of:
Monas cuspurpureus Went 1-5 weight portion Radix Paeoniae Rubra 1-5 weight portion Carapax Trionycis 3-8 weight portion
The crude drug composition of pharmaceutical composition of the present invention is preferably:
Monas cuspurpureus Went 3 weight portion Radix Paeoniae Rubra 3 weight portion Carapax Trionycis 5 weight portions
The crude drug composition of pharmaceutical composition of the present invention is preferably:
Monas cuspurpureus Went 2 weight portion Radix Paeoniae Rubra 4 weight portion Carapax Trionycis 7 weight portions
The crude drug composition of pharmaceutical composition of the present invention is preferably:
Monas cuspurpureus Went 4 weight portion Radix Paeoniae Rubra 2 weight portion Carapax Trionycis 4 weight portions
Pharmaceutical composition of the present invention adds conventional adjuvant, according to common process, makes the dosage form of clinical acceptance.Described dosage form is tablet, capsule, powder, soft capsule, drop pill, honeyed pill, pill, granule, soft extract with bee honey agent, slow releasing preparation, quick releasing formulation, controlled release preparation, oral liquid, lyophilized injectable powder or ejection preparation.
Medicine composite for curing prostate hyperplasia effect of the present invention significantly and have no side effect.
Experiment and embodiment are used to further specify but are not limited to the present invention below.
Pharmaceutical composition of the present invention (forming by water extract) reaches more than 96% through clinical treatment prostate hyperplasia 150 routine patient's total effective rates, prostate hyperplasia case diagnosis standard and criterion of therapeutical effect are pressed the Ministry of Public Health standard and are confirmed, 124 routine produce effects wherein, 19 examples effectively, 7 examples are invalid.See the following form
| Criterion of therapeutical effect | Produce effects (routine number) | Effectively (routine number) | Invalid (routine number) |
| 150 examples | 124 examples | 19 examples | 7 examples |
| Effective percentage | 83％ | 13％ | 4％ |
Following embodiment all can realize the effect of above-mentioned experimental example.
The specific embodiment
Embodiment 1:
Monas cuspurpureus Went 3kg Radix Paeoniae Rubra 3kg Carapax Trionycis 5kg
Said medicine adds conventional adjuvant according to common process and makes capsule.
Embodiment 2:
Monas cuspurpureus Went 2kg Radix Paeoniae Rubra 4kg Carapax Trionycis 7kg
Said medicine adds conventional adjuvant according to common process and makes oral liquid.
Embodiment 3:
Monas cuspurpureus Went 4kg Radix Paeoniae Rubra 2kg Carapax Trionycis 4kg
Said medicine adds conventional adjuvant according to common process and makes slow releasing tablet.
Embodiment 4:
Monas cuspurpureus Went 2kg Radix Paeoniae Rubra 2kg Carapax Trionycis 3kg
Said medicine adds conventional adjuvant according to common process and makes lyophilized injectable powder.
Embodiment 5:
Monas cuspurpureus Went 4kg Radix Paeoniae Rubra 4kg Carapax Trionycis 8kg
Said medicine adds conventional adjuvant according to common process and makes injection.
Claims (10)
1. pharmaceutical composition for the treatment of prostate hyperplasia is characterized in that the crude drug of this pharmaceutical composition consists of:
Monas cuspurpureus Went 1～5 weight portion Radix Paeoniae Rubra 1～5 weight portion Carapax Trionycis 3～8 weight portions.
2. pharmaceutical composition according to claim 1 is characterized in that this pharmaceutical composition crude drug consists of:
Monas cuspurpureus Went 3 weight portion Radix Paeoniae Rubra 3 weight portion Carapax Trionycis 5 weight portions.
3. pharmaceutical composition according to claim 1 is characterized in that this pharmaceutical composition crude drug consists of:
Monas cuspurpureus Went 2 weight portion Radix Paeoniae Rubra 4 weight portion Carapax Trionycis 7 weight portions.
4. pharmaceutical composition according to claim 1 is characterized in that this pharmaceutical composition crude drug consists of:
Monas cuspurpureus Went 4 weight portion Radix Paeoniae Rubra 2 weight portion Carapax Trionycis 4 weight portions.
5. as the described pharmaceutical composition of one of claim 1-4, it is characterized in that said composition adds conventional adjuvant,, make the dosage form of clinical acceptance according to common process.
6. the pharmaceutical composition of pharmaceutical composition as claimed in claim 5 is characterized in that this dosage form is tablet, capsule, powder, pill, granule, soft extract with bee honey agent, slow releasing preparation, quick releasing formulation, controlled release preparation, oral liquid or ejection preparation.
7. pharmaceutical composition as claimed in claim 6 is characterized in that described capsule is a soft capsule, and described pill is drop pill or honeyed pill, and described ejection preparation is a lyophilized injectable powder.
8. as the application of the described pharmaceutical composition of one of claim 1-4 in the medicine of preparation treatment prostate hyperplasia.
9. as the described preparation of drug combination method of one of claim 1-4, it is characterized in that this method is: said composition adds conventional adjuvant, according to common process, make tablet, capsule, powder, pill, granule, soft extract with bee honey agent, slow releasing preparation, quick releasing formulation, controlled release preparation, oral liquid or ejection preparation.
10. preparation of drug combination method as claimed in claim 9 is characterized in that described capsule is a soft capsule, and described pill is drop pill or honeyed pill, and described ejection preparation is a lyophilized injectable powder.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008101067874A CN101579412B (en) | 2008-05-15 | 2008-05-15 | Medicinal composition for treating prostatauxe and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008101067874A CN101579412B (en) | 2008-05-15 | 2008-05-15 | Medicinal composition for treating prostatauxe and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101579412A CN101579412A (en) | 2009-11-18 |
| CN101579412B true CN101579412B (en) | 2011-04-20 |
Family
ID=41361817
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008101067874A Active CN101579412B (en) | 2008-05-15 | 2008-05-15 | Medicinal composition for treating prostatauxe and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101579412B (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1163761A (en) * | 1996-04-26 | 1997-11-05 | 李建平 | Qianliehuixiao pill for treating prostatitis and prostatic hyperplasia |
| CN1294013A (en) * | 1999-10-26 | 2001-05-09 | 马俊杰 | Medicine for treating prostatic hyperplasia |
| CN101053624A (en) * | 2007-05-23 | 2007-10-17 | 李红 | Traditional Chinese medicinal for treating prostatic hyperplasia and chronic prostatitis and its preparation process |
-
2008
- 2008-05-15 CN CN2008101067874A patent/CN101579412B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1163761A (en) * | 1996-04-26 | 1997-11-05 | 李建平 | Qianliehuixiao pill for treating prostatitis and prostatic hyperplasia |
| CN1294013A (en) * | 1999-10-26 | 2001-05-09 | 马俊杰 | Medicine for treating prostatic hyperplasia |
| CN101053624A (en) * | 2007-05-23 | 2007-10-17 | 李红 | Traditional Chinese medicinal for treating prostatic hyperplasia and chronic prostatitis and its preparation process |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101579412A (en) | 2009-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101385848B (en) | Medicine for treating bronchitis | |
| CN102247581B (en) | Medicament for treating myoma of uterus | |
| CN101983644A (en) | Medicament for treating sequelae of apoplexy | |
| CN104248722A (en) | Medicament for treating female hypersexuality | |
| CN103877508A (en) | Traditional Chinese medicine composition for treating metrocarcinoma | |
| CN102139051A (en) | Application of soft capsule capable of clearing heat and eliminating toxin in preparation of medicament for treating viral pneumonia | |
| CN101579412B (en) | Medicinal composition for treating prostatauxe and preparation method thereof | |
| CN104491459A (en) | Traditional Chinese medicine composition for treating tumors | |
| CN101579410B (en) | Medicinal composition for treating prostatauxe | |
| CN102397326A (en) | Formula of Chinese angelica-motherwort herb decoction and preparation thereof | |
| CN101579389B (en) | Medicinal composition for treating osteoporosis | |
| CN103585597A (en) | Traditional Chinese medicine composition for relieving severe pain caused by renal calculus | |
| CN104689020A (en) | Detoxication pill for bladder cancer | |
| CN101579379B (en) | Medicinal composition for treating senile dementia and preparation method thereof | |
| CN104042705B (en) | One treats prostatitic Chinese medicine composition and preparation method and application | |
| CN103611062B (en) | A kind of Chinese medicine composition for the treatment of diabetes insipidus | |
| CN101579386B (en) | Medicinal composition for treating anorexia nervosa | |
| KR20170136213A (en) | Chinese medicine composition | |
| CN101584763B (en) | Medicinal composition for treating chronic cystitis and preparation method thereof | |
| CN101579435B (en) | Medicinal composition for treating adiposity and preparation method thereof | |
| CN106491692A (en) | A kind of coldrex | |
| CN101757137A (en) | Medication for treating mixed hemorrhoids and preparation method thereof | |
| CN101579387B (en) | Medicinal composition for treating anorexia nervosa and preparation method thereof | |
| CN104587071A (en) | Traditional Chinese medicament for treating infantile blood-heat allergic purpura | |
| CN104013943A (en) | Traditional Chinese medicine (TCM) preparation for treating beriberi |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |